Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-01-16 to 2025-01-17
Current total value of award: $58.06
Description: 4566964374!CLONAZEPAM 0.25 MG ODT UD 60S